相关实验视频
Updated: Jun 6, 2025

07:49
Measuring Local Anaphylaxis in Mice
Published on: October 14, 2014
19.3K
注射性上腺素的替代方案用于治疗过敏反应
Guillaume Pouessel1,2,3, Catherine Neukirch4,5
1Service de Pédiatrie, Pavillon Médicochirurgical de Pédiatrie, Boulevard Lacordaire, Roubaix, France.
概括
新的上腺素鼻喷雾剂为过敏反应治疗提供了自动注射器的替代方案. 这些创新设备可以改善药物使用和有效性,解决当前上腺素自动注射器 (AAI) 的局限性.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
- 医疗器械 医疗器械
背景情况:
- 过敏反应需要立即接受上腺素治疗.
- 上腺素自动注射器 (AAI) 是标准的,但存在限制,阻碍了使用.
- 目前正在探索替代的给药途径,以改善过敏反应的管理.
研究的目的:
- 在过敏反应治疗中审查AAI的限制.
- 总结使用替代路线的新型上腺素输送装置的数据.
- 讨论非注射性上腺素在过敏反应中的潜力.
主要方法:
- 关于AAI限制和障碍的文献综述.
- 替代性上腺素装置的药理动力学,药理动力学和安全性数据的摘要.
- 对经批准的非注射性上腺素装置进行分析.
主要成果:
- 有关药物有显著的局限性,导致使用不足.
- 正在开发用于鼻腔,舌下和透皮上腺素输送的新型设备.
- 第一个非注射性上腺素装置 (鼻喷雾) 已被批准用于特定的患者群体.
结论:
- 非注射性上腺素装置有望改善过敏反应治疗.
- 这些创新可能会克服一些AAI的局限性,可能会增加上腺素的使用.
- 预计很快将有多种可替代注射性上腺素的替代品,从而加强过敏反应护理.
相关概念视频
Adrenergic Agonists: Therapeutic Uses
731
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
731
Allergic Reactions
27.2K
Overview
27.2K
Adrenergic Agonists: Mixed-Action Agents
664
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
664
Adrenergic Agonists: Direct-Acting Agents
1.4K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.4K
Adrenergic Agonists: Therapeutic Classification
718
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
718
Drug Delivery: Enteral Route
383
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
383

